SpecGx, LLC recalls Oxycodone and Acetaminophen CII Tablets USP
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
- Products
-
- Oxycodone and Acetaminophen CII Tablets USP
- Company
- SpecGx, LLC
- Where it was sold
-
Nationwide
Nationwide
- Units affected
- 74,544 bottles
- About this recall
- Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493